Viralytics Ltd (VLA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Viralytics Ltd (VLA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH4174D
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Viralytics Ltd (Viralytics), formerly Psiron Limited is a biotechnology company that develops oncology products. The company develops and markets oncolytic immunotherapies for the treatment of different types of cancers. It offers cavataktm, a proprietary formulation for the common cold Coxsackievirus Type A21 (CVA21), is being evaluated in phase 1 and 2 clinical trials. Viralytics' cavataktm is an oncolytic common cold virus that has demonstrated anti-tumor activity, by following a process called lysis. The company's products are evaluated both as an intratumoural and intravenous agent in melanoma, prostate, lung and bladder cancers. It conducts research and development through medical research institutes and research facilities in Newcastle, Australia. Viralytics is headquartered in Sydney, New South Wales, Australia.

Viralytics Ltd (VLA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Viralytics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Viralytics Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Viralytics Enters into Agreement with Merck 10

Equity Offering 10

Viralytics Raises USD3 Million in Share Purchase Plan 10

Viralytics Raises USD20.8 Million in Private Placement of Shares 12

Viralytics Completes Second Tranche Of Private Placement Of Shares For US$20.2Million 13

Viralytics Completes Rights Offering Of Shares For US$3.6 Million 15

Viralytics Ltd-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Product News 20

11/22/2016: Viralytics Announces Formation of Clinical Advisory Board 20

03/15/2016: Positive CAVATAK Clinical Data Presented at 2016 European Association of Urology Congress 21

Clinical Trials 22

Apr 05, 2017: Viralytics moves into the Expansion Phase and Reports on Progress in the CAVATAK and KEYTRUDA Combination KEYNOTE-200 clinical trial at AACR Conference 22

Apr 05, 2017: Viralytics' CAVATAK in Combination with YERVOY Provides Promising Results in Advanced Melanoma from the Phase 1b MITCI clinical study 23

Mar 02, 2017: Viralytics to Present New CAVATAK Clinical Data at American Association for Cancer Research Annual Meeting 2017 25

Oct 04, 2016: Viralytics Presents CAVATAK Trial Results at Oncolytic Virus Therapeutics Conference 27

Jun 06, 2016: Updated clinical trial data on CAVATAK tumour targeting and immune-activation presented at the American Society Clinical Oncology Annual Meeting 29

Apr 19, 2016: Positive Clinical Data from CAVATAK and YERVOY Combination presented at the 2016 AACR Annual Meeting 31

Apr 18, 2016: Further Promising CAVATAK Trial Data to be presented at Association for Cancer Research Annual Meeting 32

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34

List of Figures

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

List of Tables

Viralytics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Viralytics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Viralytics Ltd, Deals By Therapy Area, 2011 to YTD 2017 8

Viralytics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Viralytics Enters into Agreement with Merck 10

Viralytics Raises USD3 Million in Share Purchase Plan 10

Viralytics Raises USD20.8 Million in Private Placement of Shares 12

Viralytics Completes Second Tranche Of Private Placement Of Shares For US$20.2Million 13

Viralytics Completes Rights Offering Of Shares For US$3.6 Million 15

Viralytics Ltd, Key Competitors 17

Viralytics Ltd, Key Employees 18

Viralytics Ltd, Other Locations 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Viralytics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16145
Site License
USD 500 INR 32290
Corporate User License
USD 750 INR 48435

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com